Broderick Brian C Abbott Laboratories Transaction History

Broderick Brian C

  • $453 Million
  • Q2 2024

A detailed history of Broderick Brian C transactions in Abbott Laboratories stock. As of the latest transaction made, Broderick Brian C holds 115,586 shares of ABT stock, worth $13 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares
115,586
Previous 108,284 6.74%
Holding current value
$13 Million
Previous $12.3 Million 2.41%
% of portfolio
2.65%
Previous 2.86%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$100.73 - $112.44 $735,530 - $821,036
7,302 Added 6.74%
115,586 $12 Million
Q1 2024

May 03, 2024
BUY
$109.52 - $120.96 $806,067 - $890,265
7,360 Added 7.29%
108,284 $12.3 Million
Q4 2023

Feb 13, 2024
BUY
$90.19 - $110.4 $350,748 - $429,345
3,889 Added 4.01%
100,924 $11.1 Million
Q3 2023

Nov 14, 2023
BUY
$95.53 - $114.62 $141,766 - $170,096
1,484 Added 1.55%
97,035 $9.4 Million
Q2 2023

Aug 11, 2023
BUY
$100.78 - $112.29 $4,232 - $4,716
42 Added 0.04%
95,551 $10.4 Million
Q1 2023

May 10, 2023
SELL
$96.86 - $114.01 $6,586 - $7,752
-68 Reduced 0.07%
95,509 $9.67 Million
Q4 2022

Feb 09, 2023
SELL
$95.06 - $111.52 $110,269 - $129,363
-1,160 Reduced 1.2%
95,577 $10.5 Million
Q3 2022

Nov 08, 2022
BUY
$96.76 - $112.03 $300,923 - $348,413
3,110 Added 3.32%
96,737 $9.36 Million
Q2 2022

Jul 19, 2022
SELL
$102.07 - $123.37 $32,968 - $39,848
-323 Reduced 0.34%
93,627 $10.2 Million
Q1 2022

May 17, 2022
BUY
$114.02 - $139.04 $26,908 - $32,813
236 Added 0.25%
93,950 $11.1 Million
Q4 2021

Feb 08, 2022
BUY
$115.53 - $141.46 $299,222 - $366,381
2,590 Added 2.84%
93,714 $13.2 Million
Q3 2021

Nov 10, 2021
SELL
$116.66 - $129.06 $100,210 - $110,862
-859 Reduced 0.93%
91,124 $10.8 Million
Q2 2021

Aug 09, 2021
SELL
$105.79 - $124.53 $11,848 - $13,947
-112 Reduced 0.12%
91,983 $10.7 Million
Q1 2021

May 17, 2021
SELL
$108.84 - $128.23 $94,581 - $111,431
-869 Reduced 0.93%
92,095 $11 Million
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $17,640 - $19,222
-168 Reduced 0.18%
92,964 $10.2 Million
Q3 2020

Oct 28, 2020
BUY
$91.64 - $111.29 $93,014 - $112,959
1,015 Added 1.1%
93,132 $10.1 Million
Q2 2020

Jul 28, 2020
SELL
$76.57 - $98.0 $141,960 - $181,692
-1,854 Reduced 1.97%
92,117 $8.42 Million
Q1 2020

May 07, 2020
SELL
$62.82 - $91.86 $16,710 - $24,434
-266 Reduced 0.28%
93,971 $7.42 Million
Q4 2019

Jan 15, 2020
SELL
$78.51 - $87.4 $79,452 - $88,448
-1,012 Reduced 1.06%
94,237 $8.19 Million
Q3 2019

Nov 04, 2019
SELL
$81.84 - $88.74 $146,657 - $159,022
-1,792 Reduced 1.85%
95,249 $7.97 Million
Q2 2019

Jul 24, 2019
SELL
$72.88 - $85.0 $216,162 - $252,110
-2,966 Reduced 2.97%
97,041 $8.16 Million
Q1 2019

Apr 29, 2019
SELL
$66.22 - $80.06 $166,410 - $201,190
-2,513 Reduced 2.45%
100,007 $8 Million
Q4 2018

Jan 24, 2019
SELL
$65.56 - $74.27 $1.13 Million - $1.28 Million
-17,278 Reduced 14.42%
102,520 $7.41 Million
Q3 2018

Oct 15, 2018
SELL
$60.81 - $73.36 $3,770 - $4,548
-62 Reduced 0.05%
119,798 $8.79 Million
Q2 2018

Jul 30, 2018
BUY
$57.57 - $63.54 $269,715 - $297,684
4,685 Added 4.07%
119,860 $7.31 Million
Q1 2018

Apr 24, 2018
SELL
$56.27 - $63.62 $69,493 - $78,570
-1,235 Reduced 1.06%
115,175 $6.9 Million
Q4 2017

Feb 02, 2018
SELL
$53.68 - $57.47 $475,604 - $509,184
-8,860 Reduced 7.07%
116,410 $6.64 Million
Q3 2017

Oct 26, 2017
BUY
$48.06 - $53.64 $6.02 Million - $6.72 Million
125,270
125,270 $6.69 Million

Others Institutions Holding ABT

# of Institutions
3,137
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email